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Fonction, la Structure et l’Inge´nierie des Prote´ines, Universite´ Laval, Quebec City, Quebec, CanadaABSTRACT Knowledge about the influenza fusion peptide (FP) membrane insertion mode is crucial for understanding its
fusogenic mechanism. NMR and electron paramagnetic resonance experiments showed that in micelles, the FP inserted as
a fixed-angle inverted V. In membranes, however, it was shown to insert as a straight a-helix (by molecular-dynamics simula-
tions) and to adopt multiple kinked conformations (by solid-state NMR). In this work we performed explicit-solvent molecular-
dynamics simulations of the influenza FP, and its F9A and W14A mutants, in POPC membranes. The 1Ha chemical shifts
predicted from the molecular-dynamics structures are in excellent agreement with the experimental values obtained for the three
peptides. The peptide orientation and conformations observed from the simulations lead to a flexible flat-V model in which the
peptide lies almost flat on the membrane surface and alternates between kinked and straight-helix conformations.INTRODUCTIONA flu infection starts with the entry of an influenza virus into
a host cell. To accomplish this, the virus binds to the host
cell surface receptors, is endocytosed, and fuses its
membrane with the endosomal membrane (1–3). The
binding and membrane fusion steps are mediated by hemag-
glutinin (HA), a glycoprotein embedded in the viral
membrane. HA is a homotrimer whose monomers are
each composed of two disulfide-bound subunits (4). The
20 N-terminal residues of HA2, the second subunit of HA,
constitute the fusion peptide (FP), the only part of HA
that inserts into the endosomal membrane during the fusion
process (5). It was also shown that FPs alone, without the
rest of HA, catalyze membrane fusion in a pH-dependent
manner (6,7). The establishment of a comprehensive model
for membrane fusion catalysis by the FP is required for the
development of membrane fusion inhibitors with the ability
to prevent infection (8,9).
The structure of the peptide was previously resolved from
NMR experiments in dodecylphosphocholine (DPC)
micelles at fusogenic pH 5, and consists of two helices linked
by a kink at a fixed angle (10,11). The membrane insertion
was estimated from electron paramagnetic resonance
(EPR) experiments, and the results indicate that the FP
with this rigid structure inserts intomembranes as an inverted
V, with the two termini pointing toward the center of the
membrane, and residue N12 at the apex of the angle struc-
ture. Membrane fusion is impaired by mutations that disturb
the kink, supporting the notion that the fixed-angle kink is
essential for fusogenicity (11,12). The inverted-V insertion
was also observed to be stable in membranes in several short
molecular-dynamics (MD) simulations (13–16). However,Submitted October 11, 2011, and accepted for publication April 3, 2012.
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this fixed-angle inverted-V model. From different NMR
experiments, it was observed that the FP takes multiple
kinked conformations (17,18) or has a flexible hinge
(19–21). In addition, some longer MD simulations also re-
vealed straight helical conformations (22,23) with some flex-
ibility (23). Finally, recent NMR experiments showed that
the peptide adopts a tight hairpin conformation (24) similar
to the pronounced kink found in MD simulations (25).
Peptide sequences vary from one NMR study to another,
but in every case they differ from the original 20-amino-acid
sequence that was used in this work because it is extremely
aggregative and poorly soluble in aqueous media. This
problem was experimentally overcome by the addition of
few amino acids at the C-terminus (10,17,18,21,24,26), or
by the mutation of a few residues (19,20). The additional
C-terminal sequence consists of a few conserved residues
from the original HA2 sequence (21), a few apolar residues
followed by four lysines (10,17,18), or both approaches
combined (24,26) (in the latter references, the peptide
sequence was from a different strain). Considering only
experiments performed with a peptide that includes the
same FP amino sequence used in this work, the FP was
found in different conformations: with a fixed-angle in-
verted-V structure (10), with multiple kinked conformations
(17,18), and in equilibrium between helical and nonhelical
conformations (21). Therefore, we propose that the FP is
flexible, and this flexibility allows the multiple conforma-
tions reported in the literature.
In this work. we conducted a total of 4.8 ms of explicit-
solvent MD simulations of the wild-type (WT) FP and
two mutants, F9A and W14A, in 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) membranes. Residues
F9 and W14 are located on each side of the FP kink, and
F9A mutant was found to conserve fusogenicity and a
fixed-angle kink (12), whereas W14A did not (11). Straightdoi: 10.1016/j.bpj.2012.04.003
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from the trajectories for the WT, with a predominance of
straight helical conformations, in agreement with the spec-
troscopic measurements of Chang et al. (21). The WT lies
almost flat on the membrane, as a flexible flat V, in contrast
to the fixed-angle inverted V found in micelles (10). The
length of our simulations allowed conformational transi-
tions between straight helical and kinked conformations,
supporting the hypothesis of a flexible FP in membranes.
The F9A and W14A mutants adopt a flexible flat V confor-
mation in membranes as well. However, these mutants are
more flexible than the WT, with W14A being the most flex-
ible, consistent with a broad kink angle distribution
observed experimentally (11,12), and can adopt a hairpin
conformation, or unfold at the C-terminus in the case of
W14A. The 1Ha chemical shifts predicted from the MD
conformations are in excellent agreement with the experi-
mental values obtained for the three peptides (11,12,27).FIGURE 1 (Color online only). Side views of the (A) straight helix andMETHODS
Peptides in POPC bilayers
The FP of type 3 HA from influenza virus strain X-31 with sequence
GLFGA-IAGFI-ENGWE-GMIDG (hereafter referred to as the WT) was
studied along with its F9A and W14A mutants. The starting conformations
for the WT simulations were selected among the 20 NMR structures of the
peptide in DPC micelles at pH 5.0 from Protein Data Bank (PDB) entry
1IBN (10). Four models (models 1, 5, 12, and 19) were chosen for the pres-
ence or absence of some hydrogen (H)-bonds that stabilize the kinked struc-
ture as described previously (16). Four starting conformations for each
mutant were also used. These conformations were derived from the WT
conformations, where the coordinates of mutated side chains were deter-
mined using the internal coordinates from CHARMM topology files (28).
The neutral glycine (GLYN) patch was used for the first residues, and the
amidated C-terminus (CT2) patch was used for the last residues. The
GLYN patch was adapted from the CHARMM22 topology as described
previously (16). Glutamic and aspartic acids were unprotonated according
to common methods (13–16,22,23). It was previously proposed that at least
E11 is protonated at pH 5 (18,20), and that protonation would influence the
FP insertion depth (23,25) but not its conformations (25,29).
For each of the four initial structures, the peptide was put in place at the
position and orientation in bilayers suggested by the work of Han et al. (10),
i.e., the Ca of N12 at the average position of the lipid phosphate groups
(~19 A˚ from the bilayer center (30)), and an angle of 37 with the bilayer
plane for the N-terminal helix formed by residues 2–10. Next, the initial
configuration of the bilayer around the peptide was constructed from
pre-equilibrated and prehydrated POPC lipids as described previously
(31–33), with a cross-sectional area of 64 A˚2 per lipid (34). The POPC
bilayer consisted of 123 lipids (64 for the lower leaflet and 59 for the upper,
where the peptide stands), and ~30 water molecules for each lipid. Finally,
10 Cl and 13 Naþ ions were added for a concentration ofz150 mM NaCl
via random replacement of water molecules >6 A˚ away from any solute or
previously placed ion.
(B) kinked conformations of the WT FP. The straight helix and kinked
conformations account for ~70% and ~30% of the WT sampling, respec-
tively. Peptide backbone in blue cartoon. Hinge region residues N12 and
G13 in red cartoon. Residues mutated in this work (F9 and W14) are in
spheres, heavy atoms are in green, and hydrogens are in pale green.
Membrane lipids are in spheres, head and tails are in white, and phosphates
are in gray. The image was built with the PyMOL molecular graphics
system, version 1.2r2 (Schro¨dinger, LLC).Simulations
For each of the three peptides studied (WT, F9A, and W14A), we produced
eight 200-ns trajectories, for a total of 24 trajectories. First, we calculated
four 200-ns trajectories for each peptide using the starting conformations
selected from NMR models, as described in the previous section. Wethen used the final conformations obtained from this first series of WT
simulations as starting conformations for a second series of four 200-ns
simulations of each peptide. This yielded simulations of mutant peptides
starting from both experimental structures and structures equilibrated
with the WT sequence. For each trajectory, the peptide was held fixed for
the first 10 ns, and the first 50 ns were considered as equilibration and dis-
carded from analysis. This provided a total of 1.2 ms of equilibrated
sampling for each peptide.
Simulations were performed with the program NAMD2 (35) using the
CHARMM27r force field (36) with the CMAP correction (37), TIP3P
waters (38,39), revised tryptophane parameters (40), and periodic boundary
conditions. The cutoff for the short-range electrostatics and the Lennard-
Jones interactions was 11 A˚, with the latter smoothed via a switching
function over the range of 8–11 A˚. Long-range electrostatics were calcu-
lated via the particle mesh Ewald (PME) method (41), using a sixth-order
interpolation and a grid spacing ofz1 A˚. NPT ensembles were generated
at 30C by Langevin dynamics with a damping coefficient of 1 ps1.
Isotropic pressure was controlled by a Nose´-Hoover Langevin piston
at z210 5 10 bar to account for long-range Lennard-Jones terms
following the long-range correction method (42). Pressure for the long-
range correction method was updated every 10 ns with a long cutoff at
30 A˚. All covalent bonds involving hydrogen atoms were constrained using
SHAKE (43), and drifting of the center of mass due to PME was removed.
The simulations used a 2-fs time step with the multiple time steps r-RESPA
integrator updating bonded, van der Waals, and short-range electrostatics
every step, and long-range electrostatics updated every 2 steps. Nonbonded
pair lists were updated every 10 steps and coordinates were saved every
10 ps for analysis.RESULTS AND DISCUSSION
Position and orientation in the bilayer
Fig. 1 shows the two typical conformations (straight helix
(Fig. 1 A) and kinked (Fig. 1 B)) that the WT in a POPC
bilayer experienced during the simulations (a detailed
analysis of the conformations is given in the next section).
Starting from the inverted-V model proposed by Han et al.
(10), the peptide changes conformation and reorients in all
of the trajectories within 50 ns after removal of constraints
on the peptide’s position. It then adopts either a straight
a-helical or kinked conformation and lies almost flat inBiophysical Journal 102(10) 2270–2278
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the consequence of a balance between hydrophilic and
hydrophobic forces, and the reorganization of the backbone
H-bonds.
The peptide’s solvent-accessible surface area (SASA)
was calculated from the equilibrated part of the trajectories.
Table S1 in the Supporting Material gives the values for the
whole peptide and for each residue of the three peptides. For
the WT, the SASA is 402.83 5 11.90 A˚2 for the whole
peptide. The 10 residues of the C-terminal are exposed to
the solvent to a greater extent than the 10 residues of the
N-terminal (313.39 5 13.64 A˚2 and 89.44 5 5.40 A˚2,
respectively). This is not a surprising result considering
that seven out of 10 of the hydrophobic residues are located
in the N-terminal half of the peptide, and all of the hydro-
philic residues are located in the C-terminal half. This
amino-acid distribution gives rise to a hydrophobic gradient
along the peptide’s sequence that is not compatible with the
inverted-V conformation proposed by Han et al. (10), and
leads to the peptide’s shallow tilt insertion angle observed
in the simulations. However, the greater exposure of the
second half of the peptide to the solvent was also observed
experimentally from amide D-H exchanges (21). The total
SASAs of F9A and W14A are significantly higher than
that for the WT, with a larger exposure for F9A
(442.275 10.66 A˚2 and 426.305 17.52 A˚2, respectively).
The average insertion depth of each residue relative to the
average lipid phosphate position for the three peptides are
plotted in Fig. 2 (WT insertion depths are compared with
the experimental results of Han et al. (10) in Fig. S1). The
three insertion profiles are similar, with the WT inserted
slightly deeper than the mutants, in accord with the lowest
SASA reported above. As shown in Fig. 2, the N-termini
are inserted deeper than the C-termini, with residues D19
at the apex, in agreement with amide D-H exchange exper-
iments (21) for the WT, giving rise to a shallow tilt angle
from the bilayer plane uniformly over the two termini.
The insertion of the WT N-terminal half is in good agree-
ment with the experimental results of Han et al. (10)FIGURE 2 Side-chain insertion depths under the phosphates per residue.
Side-chain heavy atoms were used for the calculations. The WT peptide
inserts 0.6 5 0.2 A˚ deeper into the membrane than the two mutants.
Biophysical Journal 102(10) 2270–2278(Fig. S1). For the WT C-terminal half, N12 has an insertion
depth radically different from the EPR results (z8 A˚ above
the lipid phosphates), but the remaining residues display
a similar insertion, with a slightly shallower insertion of
the C-terminus from MD simulations. The difference in
C-terminal insertion depth as compared with the work of
Han et al. may be due to the unprotonated state of the three
ionizable residues located in this segment used in MD simu-
lations, because it was previously observed that the proton-
ation of these residues favors a slightly deeper insertion into
the membrane (10,21,23,25). The N12 Ca average insertion
depths are 2.25 0.2 A˚ for WT, 1.25 0.5 A˚ for F9A, and
1.4 5 0.4 A˚ for W14A under the phosphate average posi-
tion. Despite a different side-chain insertion depth, the Ca
insertion depth of N12 of the WT is in very good agreement
with the prediction of Han et al. (10), who placed this
residue at the same position as the lipid phosphate groups
along the bilayer normal, and is also in agreement with
the membrane location of this residue observed from amide
D-H exchange experiments (21). Nevertheless, these results
are in contrast to the inverted-V model of Han et al. (10),
where N12 is at the apex with its side chain z8 A˚ above
the lipid phosphates. However, the uniform tilt for the WT
was also observed from the experimental results of Macosko
et al. (44) and from implicit-solvent simulations of Sammal-
korpi and Lazaridis (23). Moreover, this uniform tilt angle
over both termini is in accord with the hydrophobic gradient
observed along the peptide’s sequence.
We calculated the orientation of the peptides relative to
the membrane plane from the trajectories using the peptide
order parameters SATR, as described in a previous work (16).
The tilt angle is identical within standard errors for both
termini and the three peptides, with an average value of
19 5 2. The experimental values for this tilt angle range
from z20 (45) to z45 (46) for the whole peptide,
whereas Han et al. (10) obtained an angle of 38 for the
N-terminal segment using spin-label insertion depth profiles
from site-specific mutations and EPR data. However, small
tilt angles were reported in several previous MD studies
(22,23,25).Conformations and secondary structures
Fig. 3 shows, for each of the three peptides studied in this
work, 20 conformations extracted from equally spaced
snapshots taken from their respective 1.2 ms of equilibrated
trajectories. These results indicate that the three peptides
adopt predominantly a straight-helix conformation but
can also adopt other conformations. The straight-helix
conformations account for 69% of the observed conforma-
tions for the WT, and for 60% and 44% for the F9A
and W14A mutants, respectively. The remaining conforma-
tions observed for the WT are the kinked conformations
(31%). For F9A, the remaining conformations are kinked
(35%) and hairpin (5%), whereas W14A visits kinked
FIGURE 3 (Color online only). Top-view 20 conformations of the WT
(top), F9A mutant (middle), and W14A mutant (bottom) FPs taken from
equidistant frames of the 1.2-ms-long total equilibrated simulation time.
Helical (green), kinked (blue), hairpins (yellow), and unfolded C-termini
(red) conformations are shown.
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FIGURE 4 Backbone H-bond patterns found in PDB 1IBN and for the
different conformations adopted by the three peptides. Each number refers
to a residue. Each line represents an H-bond between the carbonyl of the
residue on the left and the amine of the residue on the right. Plain lines
are drawn for H-bonds that are present in 60–100% of the structures.
Dashed lines are drawn for bonds that are present in 20–60% of the struc-
tures. H-bonds are defined by a distance of %2.4 A˚ between the carbonyl
oxygen and the amine hydrogen. Numerical values of the occurrences of
each H-bond are given in Table S2.
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conformations.
We quantified the helicity of the peptides from the helical
fraction of each residue (i.e., the fraction of time each
residue spent in the helical conformation throughout the
simulations) as determined using Kabsch and Sander’s
(47) definition of an a-helix. The helical fractions were
calculated for the three peptides and from the PDB 1IBN,
and the results are presented in Fig. S2. As shown in the
figure, the simulated peptides display identical helicity for
residues 1–11 despite the mutation of F9A in this region,
whereas the helicity for the second half of the peptides
differs, with some similarities between WT and F9A. The
lower helicity of residues 12–20 of W14A is due to its un-
folding. The helicity of WTand 1IBN is similar for residues
4–9, but it strongly differs for the kink region, where resi-
dues 11–13 of 1IBN are in a turn configuration. Finally,the second helix of 1IBN, defined by residues 15–18, has
a slightly higher helicity than the WT. As for the WT MD
simulations, Chang et al. (21) also observed from nuclear
Overhauser effect spectroscopy a weaker helical character
for the residues in the kink region, and structural fluctua-
tions for residues located at the C-terminus.
Fig. 4 shows the backbone H-bond patterns observed in
the kink region for each peptide conformation, for 1IBN
and the three peptides. For 1IBN (Fig. 4 A), the kink is stabi-
lized by iþ3 bonds between G8 and E11, and F9 and N12, in
addition to an iþ5 bond between F9 and W14. The iþ3
bonds of G13 and W14 with G16 and M17 account
for the short 310 helix. It is observed from the trajectories
that the peptides reorganize their conformation within
50 ns after the removal of the constraints on the positions,
in the equilibration phase. The H-bond patterns adopted
by the WT are presented in Fig. 4, B and D, and those adop-
ted by F9A and W14A are presented in Fig. 4, C–E. The
kinked conformation of WT is stabilized by an H-bond
between I10 and G13 (Fig. 4 B), but there is no particular
H-bond to stabilize the kinked conformation of F9A and
W14A (Fig. 4 C). With either WT or a mutant, a straight
a-helix can be formed from the kinked conformation by
the formation of iþ4 backbone H-bonds of I10 and E11Biophysical Journal 102(10) 2270–2278
FIGURE 5 Average 1Ha chemical-shift differences between experi-
mental values (27) and SPARTAþ computed values for the WT and
1IBN structures (10). The error bars are represented only for the residues
with a significant difference from the experimental value.
2274 Le´gare´ and Lagu¨ewithW14 and E15 (Fig. 4D). The transition between kinked
and hairpin conformations of F9A and W14A is mainly
driven by apolar contacts between N- and C-terminal
helices. All of the peptide conformational transitions also
imply rotations of backbone dihedral angles of residues
N12 and G13.
These results illustrate that the FP and its mutants can
adopt multiple conformations when bound to membranes,
with the WT having the highest helical content and W14A
C-terminal unfolding. The increase in helicity was also
observed from previous MD simulations (14,16,22), and it
was suggested to be a consequence of a lower exposure of
the peptide to water solvent in membranes than in micelles
(16). From the conformations and the helical content, F9A
shares more similarities with the WT than W14A. This is
in agreement with the structural similarity between the
F9A mutant and the FP found experimentally (12). Again,
the multiple conformations observed in this work are in
contrast to the fixed-angle inverted-V model described in
the literature (10–16). Nevertheless, the flexibility observed
for the WT in this work is in agreement with previous
modeling works (23,25), the multiple conformations found
from solid-state NMR (17,18), the experimental observa-
tions of Chang et al. (21) from various spectroscopic
methods, and the experimental chemical shifts presented
in the next section.Chemical shifts
The 1Ha chemical-shift predictions for the conformations
extracted from MD simulations for the three peptides
(Fig. 3) as well as for their respective PDB structures
(1IBN, 2JRD, and 2DCI for WT, F9A, and W14A, respec-
tively) were calculated with the use of SPARTAþ (48).
SPARTAþ predictions are based on quantitative relations
between chemical shifts and protein structures derived
from a neural network training of a database of hundreds
of protein x-ray structures. The protein structure descriptors
include backbone and side-chain conformations, H-bonding,
electric fields, and ring-current effects. The chemical-shift
differences from the experimental values for the WT and
1IBN are compared in Fig. 5, and the chemical-shift differ-
ences for F9A (12) and W14A (11) and their respective
PDB structures are compared in Fig. S3 (similar membrane
protein and membrane peptide chemical-shift comparisons
are reported in Bhate et al. (49) and Ikeda et al. (50),
respectively).
The chemical-shift differences from the experimental
values are greater on average for 1IBN, with a root mean-
square deviation (RMSD) of 0.293 ppm, than for the WT,
with an RMSD of 0.158 ppm (Fig. 5). The very good agree-
ment between the WT chemical-shift predictions and the
experimental values indicate that the conformations
observed from the MD simulations in model membranes
are representative of the peptide conformations fromBiophysical Journal 102(10) 2270–2278NMR experiments in DPC micelles. Moreover, the lower
RMSDs observed for the WT than for 1IBN suggest that
the WT conformations surpass the 1IBN conformers in
terms of being representative of the experimental results.
For theWT structures, only residue G13 displays a deviation
from experimental values greater than the standard devia-
tion of 0.25 ppm inherent to the prediction method (48),
whereas there are six residues for 1IBN (I10, E11, N12,
W14, E15, and M17; Fig. 5). The greatest difference is
observed for W14, with 1.043 ppm. These differences are
discussed further below.
Residue G13 is located in the kink region, defined by
itself and residue N12. The 1Ha chemical-shift differences
between SPARTAþ predictions from MD structures and
the experimental results for the two G13 protons are
0.324 and 0.304 ppm, whereas these differences are
neglectable for neighboring residues N12 andW14. Accord-
ing to SPARTAþ, the main contribution to the chemical
shifts of these protons comes from the torsion angles
(0.271 ppm for both protons) and the ring current
(0.135 and 0.110 ppm) due to the proximity of F9 side
chain. However, G13 is the glycine with the lowest SASA
by far (see Table S1). As a consequence, G13 has its two
Has exposed only to the apolar lipid chains. Solvent mole-
cules make an important contribution to the chemical shift
through H-bonding, anisotropy of solvent molecules, polar
effects, and van der Waals interactions (51). For example,
the chemical shift of a-protons of a glycine could increase
up to z0.7 ppm depending on the polarity of the solvent
(52). However, contributions from solvent molecules are
not taken into account in the predictions of SPARTAþ,
which was trained using a database of globular proteins.
We suggest that the difference between the SPARTAþ
chemical-shift prediction of G13 1Ha and the experimental
results of Li et al. (27) arise because of the important solva-
tion of G13 by the bilayer.
For the case of 1IBN, residues E11, N12, and M17 have
higher predicted chemical shifts compared with their
Fusion Peptide Flexible Flat V 2275respective experimental values, with respective differences
of 0.369, 0.269, and 0.378 ppm, whereas their predictions
from WT structures are in very good agreement. For both
1IBN and WT, E11 and N12 Ha are located far from F9
and W14 side chains, resulting in no contribution from
the ring-current effect to the chemical shift. Moreover, the
1IBN E11 and N12 Has are inserted approximately at
the lipid phosphate level (10), where the interface is
composed mainly of waters and phosphate groups (53),
and should be hydrated and should not experience a sig-
nificant change in solvent polarity. Therefore, the main
contribution to the chemical shifts comes from the
secondary structure. Residues E11 and N12 have a higher
helical content for WT, as reported in the previous section,
that would explain the deviations observed for 1IBN.
For residue M17, the ring-current contribution is moderate
for both 1IBN and WT, although it is positive for 1IBN
(0.167 ppm) due to the proximity of the F9 side chain,
and negative for the WT (-0.110 ppm) due to the proximity
of the W14 side chain. Similarly, the secondary structure
contributions to the chemical shift are of the opposite sign
for 1IBN and WT: the amide of residue M17 is H-bonded
with the carbonyl of W14 (as in a 310 helix), whereas it is
in an a-helical structure in the WT. In addition, 1IBN
M17 Ha is in the vicinity of the D19 carbonyl backbone
in many structures, and should be located approximately
at the lipid carbonyl level in the membrane (see Han et al.
(10)), with a lower exposure to polar chemical groups.
Therefore, the results suggest that either proximity to D19
or lipid carbonyls, or the secondary structure and the side-
chain conformation may be the origin of the 1IBN M17
chemical-shift deviations.
The predicted chemical shifts of the remaining residues
from 1IBN (I10, W14, and E15) are underestimated
compared with their experimental values, with respective
differences of 0.354, 1.043, and 0.378 ppm, whereas
their predictions from WT structures are again in very
good agreement. These deviations arise mainly from large
ring-effect contributions predicted by SPARTAþ (1.379
to 0.625 ppm), due to their close proximity to W14 (for
I10 and E15) and F9 (for W14) side chains. This proximity
occurs in the inverted-V structure of 1IBN, and is not
observed from WT conformations as shown in Fig. S4.
Hence, 1IBN structural characteristics that have been
proposed to stabilize the fixed-angle inverted-V structure
(10) (i.e., close proximity of the I10 Ha and W14 side chain
and the W14 Ha and F9 side chain, and dihedral angles of
E11 and N12) conflict with the experimental chemical
shifts. Instead, the chemical shifts predicted from the MD
structures observed in this work are in very good agreement
with the experimental values.
In similarity to the WT, the chemical shifts predicted for
F9A and W14A are in better agreement with experimental
results (11,12) than those for their respective PDB structures
(Fig. S3).Flexible flat-V model
Flexibility is defined here by the ability of the peptide to
explore a number of conformations; a higher degree of flex-
ibility implies a higher number of accessible conformations.
The flexibility of the FP is apparent from Fig. 3, with WT
being the most rigid, followed by F9A, and W14A being
the most flexible. Quantitatively, the average root mean-
square fluctuations (RMSFs) of the backbone heavy atoms
relative to the average structure are 1.8 A˚, 2.2 A˚, and
2.6 A˚ for WT, F9A, and W14A, respectively. The RMSFs
from the NMR structures are 1.2 A˚ for 1IBN (WT), 0.8 A˚
for 2JRD (F9A mutant), and 1.8 A˚ for 2DCI (W14A
mutant). These values are significantly lower than those ob-
tained from the MD conformations, suggesting a higher
rigidity for the experimental structures. The W14A mutant
has the highest flexibility from both NMR and MD struc-
tures, but F9A is found to be less flexible from the NMR
structures compared with the MD structures. However,
results from both the NMR and MD approaches agree on
the higher rigidity of the WT compared to W14A.
To locate the regions with higher flexibility, we calculated
the standard deviations s of the backbone F dihedral angles
for each residue. The results are plotted in Fig. S5 for the
three peptides. Excluding the termini, the largest deviations
are observed for the hinge region (residues 12 and 13) for
the three peptides, with a maximum for the G13. As for
the RMSF, the highest deviations are observed for W14A,
followed by F9A and the WT.
For all of the peptides, transitions between kinked and
straight helical conformations were scarce, with a timescale
of z100 ns between transitions, and not observable in
shorter MD simulations. We tracked conformational transi-
tions by following the kink angle q between the N-terminal
and C-terminal helices through the trajectories. Fig. 6 shows
the kink angle for the WT trajectories starting with struc-
tures 5 and 19 of PDB 1IBN. The kink angles q < 150
correspond to the kinked conformations with the H-bond
pattern presented in Fig. 4 B. The time series of the kink
angle for the mutants and two remaining WT simulations
are plotted in Fig. S6, Fig. S7, and Fig. S8. For the WT,
as expected from the higher level of helicity of this peptide,
the main conformational change experienced is from kinked
to straight helix. The peptide explored once the reverse
change, from straight helix to kinked (Fig. 6, structure 19,
first trajectory). The WT also explored different kink angles
(Fig. 6, structure 5, both trajectories; structure 19, second
trajectory). For F9A, the straight helical conformation is
well explored but involves short-lived deviations from an
ideal helix (Fig. S7, structures 1 and 12, first trajectory).
F9A also experienced few more kink angles than the WT
during transitions to the hairpin conformation (Fig. S7,
structure 19, first trajectory). Finally, the W14A peptide
explored the greatest number of kink angles and spent the
least time as a straight helix.Biophysical Journal 102(10) 2270–2278
FIGURE 6 (Color online only). Time series of the kink angle q from WT
simulations starting with structures 5 and 19 from PDB 1IBN. For these two
structures, as with all others used in this work, an initial 200-ns simulation
(left) is performed. The final snapshot of this initial simulation is used as the
starting conformation for a second 200-ns simulation (right). Helical
conformations are in green, kinked flat-V conformations are in blue, and
inverted-V conformations are in gray.
2276 Le´gare´ and Lagu¨eThe kink angle distributions for the three peptides are
plotted in Fig. S9. The distributions of WT and F9A display
two main components, corresponding to the straight helical
and kinked conformations, whereas for W14A the distribu-
tion is wider, consistent with a higher flexibility. These
distributions are in qualitative agreement with the distance
distributions between residues F3 and I18 observed from
double electron-electron resonance spectroscopy (12). In
addition, the wider distance distribution (12) and the broad
kink angle distribution from the NMR structure (11) of
W14A support the higher flexibility we observed for this
peptide. These results underscore the importance of residue
W14 in the structural integrity of the FP.
In general, the conformations observed from the simula-
tions in this study differ from the fixed-angle kink model
proposed by Han et al. (10). In the work presented here,
the hydrophobic pocket present in the kinked conformations
is lost for the majority of conformations observed from the
trajectories. Nevertheless, the chemical shifts predicted
from the MD structures agree with the experimental values,
validating the conformations observed from the simulations.
These results are consistent with the observation that the
kinked structure is not energetically very stable (54).
However, our simulations were at least 20 times longer
than the previous MD simulations that revealed the in-
verted-V model (13–16).
The results presented in this work all point toward a flex-
ible flat-V model for the FP in membranes. We propose that
this flexible flat-V model would allow the peptide to adapt to
the strong curvature found at different stages of membraneBiophysical Journal 102(10) 2270–2278fusion. In this model, the FP lies almost flat in the plane
of the membrane and samples different conformations,
switching between straight helical and kinked conforma-
tions. This model is in agreement with the results of Chang
et al. (21), who observed a significant helical form in
equilibrium with the nonhelical form of the peptide, with
higher structural fluctuation for residues located in the
kink region, residues at the N-terminal being buried in the
lipid medium, and residues at the C-terminal being more
exposed to water.CONCLUSION
In this work, we studied the WT influenza FP and two
mutants, F9A and W14A, in POPC membranes from
4.8 ms of explicit-solvent MD simulations. The three
peptides reside at the lipid/water interface. They take either
straight a-helical or kinked conformations and lie almost
flat in the plane of the membrane. The hydrophobic gradient
along the peptide sequence is not compatible with the in-
verted-V conformation proposed by Han et al. (10) and
leads to a shallow tilt insertion angle. The nonfusogenic
W14A is the most flexible and differs from the other two
peptides in its tendency to unfold at the C-terminal helix.
These results underscore the importance of residue W14
in the structural integrity of the FP, as experimentally deter-
mined by Lai et al. (11).
To test the validity of the simulated structures, we
calculated the differences among the SPARTAþ (48) 1Ha
chemical-shift predictions, experimental values for the
MD conformations, and previously published PDB struc-
tures. The WT chemical-shift predictions are in very good
agreement with experimental values, whereas PDB 1IBN
structural characteristics that have been proposed to stabi-
lize the fixed-angle inverted-V structure (10–12) conflict
with some of the experimental chemical shifts. Excellent
agreement is also found between predicted and experi-
mental values for both mutants.
The results presented in this work point toward a flexible
flat-V model for the FP in membranes. This model differs
from the fixed-angle inverted-V model found in DPC
micelles (10–12). FP flexibility is in agreement with
previous MD simulations (23) and different NMR results
(17–21). An almost flat insertion is compatible with
modeling studies (22,23,25). The flexible flat-V model
would allow the peptide to adapt to the strong curvature
found at different stages of membrane fusion.SUPPORTING MATERIAL
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